Table 1 Demographic details of 1 L platinum eligible patients with R/M SCCHN
| Â | Overall | France | Germany | Italy | Spain | UK |
|---|---|---|---|---|---|---|
Number of physicians | 195 | 31 | 66 | 50 | 32 | 16 |
Number of patients | 577 | 114 | 117 | 130 | 117 | 99 |
Number of caregivers | 238 | 81 | 53 | 21 | 38 | 45 |
Age | ||||||
 Mean (SD) years | 62.8 (8.5) | 62.9 (8.6) | 64.2 (7.2) | 61.6 (9.6) | 60.8 (8.6) | 64.9 (7.4) |
 Under 65 years (%) | 53.6 | 50.0 | 50.4 | 60.8 | 63.2 | 40.4 |
 65 years and over (%) | 46.4 | 50.0 | 49.6 | 39.2 | 36.8 | 59.6 |
Gender (%) | ||||||
 Male | 72.3 | 83.3 | 64.1 | 72.3 | 72.6 | 68.7 |
Staging at initial diagnosis (%) | ||||||
 Stage I | 1.0 | 1.8 | 1.7 | 0.8 | 0.9 | 0.0 |
 Stage II | 10.9 | 6.1 | 6.0 | 17.7 | 14.5 | 9.1 |
 Stage III | 23.2 | 27.2 | 2.6 | 36.9 | 30.8 | 16.2 |
 Stage IVA | 11.4 | 12.3 | 6.8 | 11.5 | 19.7 | 6.1 |
 Stage IVB | 5.9 | 3.5 | 9.4 | 8.5 | 4.3 | 3.0 |
 Stage IVC | 47.3 | 49.1 | 73.5 | 24.6 | 29.9 | 64.6 |
Current staging (%) | ||||||
 Stage III | 5.7 | 2.6 | 3.4 | 12.3 | 7.7 | 1.0 |
 Stage IVA | 14.7 | 21.9 | 0.9 | 20.0 | 20.5 | 9.1 |
 Stage IVB | 13.9 | 12.3 | 8.5 | 20.8 | 17.9 | 8.1 |
 Stage IVC | 65.7 | 63.2 | 87.2 | 46.9 | 53.8 | 81.8 |
ECOG score at initial diagnosis (%) | ||||||
 0–1 | 86.2 | 76.3 | 95.8 | 80.0 | 84.6 | 96.0 |
 0 | 27.4 | 11.4 | 47.9 | 28.5 | 22.2 | 26.3 |
 1 | 58.8 | 64.9 | 47.9 | 51.5 | 62.4 | 69.7 |
 2+ | 13.5 | 23.7 | 4.3 | 18.5 | 15.4 | 4.0 |
Current ECOG score (%) | ||||||
 0–1 | 78.6 | 59.6 | 88.0 | 76.1 | 80.3 | 89.9 |
 0 | 12.7 | 2.6 | 18.8 | 12.3 | 8.5 | 22.2 |
 1 | 65.9 | 57.0 | 69.2 | 63.8 | 71.8 | 67.7 |
 2 | 21.5 | 40.4 | 12.0 | 23.8 | 19.7 | 10.1 |
Primary tumour site (%) | ||||||
 Oral cavity | 31.9 | 28.1 | 35.9 | 31.5 | 34.2 | 29.3 |
 Oropharynx | 26.7 | 38.6 | 17.9 | 20.0 | 23.1 | 36.4 |
 Hypopharynx | 17.0 | 21.1 | 12.0 | 13.1 | 18.8 | 21.2 |
 Larynx | 23.9 | 12.3 | 33.3 | 34.6 | 23.9 | 12.1 |